top of page
Finasteride

非那雄胺
Mechanism of action:
Finasteride 是一種 5α-還原酶抑制劑(5α-reductase inhibitor)。5α-還原酶負責將睪酮(testosterone)轉換為二氫睪酮(dihydrotestosterone)。Finasteride 與該酵素結合後,顯著降低二氫睪酮的生成,從而降低二氫睪酮介導的前列腺組織生長訊號。
Reference(s):
1. Smith AB et al. (2009). Finasteride in the treatment of patients with benign prostatic hyperplasia: a review. Ther Clin Risk Manag.
2. Agamia NF et al. (2016). Benign prostatic hyperplasia, metabolic syndrome and androgenic alopecia: Is there a possible relationship? Arab J Urol.
3. Vaughan ED et al. (2003). Long-term experience with 5-alpha-reductase inhibitors. Rev Urol.
bottom of page
